πŸ‡ΊπŸ‡Έ FDA
Patent

US 7271181

Inhibitors of p38

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7271181 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/06